🇺🇸 FDA
Patent

US 10555942

Emetine compounds for treatment and prevention of flavivirus infection

granted A61KA61K31/4745A61K45/06

Quick answer

US patent 10555942 (Emetine compounds for treatment and prevention of flavivirus infection) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/4745, A61K45/06, A61P, A61P31/14